LEADER 01544nam 2200397 450 001 9910146684703321 005 20230721032421.0 010 $a1-5090-8773-7 035 $a(CKB)1000000000525273 035 $a(WaSeSS)IndRDA00124237 035 $a(EXLCZ)991000000000525273 100 $a20200601d2007 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Sixth International Symposium on Parallel and Distributed Computing $eISPDC 2007 : Hagenberg, Austria, July 5-8, 2007 /$fInstitute of Electrical and Electronics Engineers 210 1$aPiscataway, New Jersey :$cInstitute of Electrical and Electronics Engineers,$d2007. 215 $a1 online resource (vii, 52 pages) 311 $a0-7695-2917-8 606 $aParallel processing (Electronic computers)$vCongresses 606 $aElectronic data processing$xDistributed processing$vCongresses 615 0$aParallel processing (Electronic computers) 615 0$aElectronic data processing$xDistributed processing 676 $a004.35 701 $aKranzlmu?ller$b Dieter$f1969-$0963742 701 $aSchreiner$b Wolfgang$f1967-$01236216 701 $aVolkert$b Jens$f1942-$01220954 712 02$aInstitute of Electrical and Electronics Engineers, 801 0$bWaSeSS 801 1$bWaSeSS 906 $aPROCEEDING 912 $a9910146684703321 996 $aThe Sixth International Symposium on Parallel and Distributed Computing$92870667 997 $aUNINA LEADER 05456nam 22010573a 450 001 9910367754503321 005 20250203235426.0 010 $a9783039214983 010 $a3039214985 024 8 $a10.3390/books978-3-03921-498-3 035 $a(CKB)4100000010106172 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/60016 035 $a(ScCtBLL)e7f826ea-1b55-4a40-a9e5-17b58487e441 035 $a(OCoLC)1163808347 035 $a(oapen)doab60016 035 $a(EXLCZ)994100000010106172 100 $a20250203i20192019 uu 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aStem Cell and Biologic Scaffold Engineering$fPanagiotis Mallis 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 210 1$aBasel, Switzerland :$cMDPI,$d2019. 215 $a1 electronic resource (110 p.) 311 08$a9783039214976 311 08$a3039214977 330 $aTissue engineering and regenerative medicine is a rapidly evolving research field which effectively combines stem cells and biologic scaffolds in order to replace damaged tissues. Biologic scaffolds can be produced through the removal of resident cellular populations using several tissue engineering approaches, such as the decellularization method. Indeed, the decellularization method aims to develop a cell-free biologic scaffold while keeping the extracellular matrix (ECM) intact. Furthermore, biologic scaffolds have been investigated for their in vitro potential for whole organ development. Currently, clinical products composed of decellularized matrices, such as pericardium, urinary bladder, small intestine, heart valves, nerve conduits, trachea, and vessels, are being evaluated for use in human clinical trials. Tissue engineering strategies require the interaction of biologic scaffolds with cellular populations. Among them, stem cells are characterized by unlimited cell division, self-renewal, and differentiation potential, distinguishing themselves as a frontline source for the repopulation of decellularized matrices and scaffolds. Under this scheme, stem cells can be isolated from patients, expanded under good manufacturing practices (GMPs), used for the repopulation of biologic scaffolds and, finally, returned to the patient. The interaction between scaffolds and stem cells is thought to be crucial for their infiltration, adhesion, and differentiation into specific cell types. In addition, biomedical devices such as bioreactors contribute to the uniform repopulation of scaffolds. Until now, remarkable efforts have been made by the scientific society in order to establish the proper repopulation conditions of decellularized matrices and scaffolds. However, parameters such as stem cell number, in vitro cultivation conditions, and specific growth media composition need further evaluation. The ultimate goal is the development of "artificial" tissues similar to native ones, which is achieved by properly combining stem cells and biologic scaffolds and thus bringing them one step closer to personalized medicine. The original research articles and comprehensive reviews in this Special Issue deal with the use of stem cells and biologic scaffolds that utilize state-of-the-art tissue engineering and regenerative medicine approaches. 606 $aBiology, life sciences$2bicssc 610 $anerve conduit 610 $atissue engineering 610 $aregenerative medicine 610 $amixed lymphocyte reaction 610 $ahistological images 610 $afuture scaffold engineering 610 $amultiparameter 610 $a3DPVS 610 $aMSCs 610 $aWnt signaling 610 $aMesenchymal Stromal Cells 610 $afactorial design 610 $anovel scaffold 610 $aWharton?s Jelly tissue 610 $astem cells 610 $aumbilical arteries 610 $aSDS 610 $aplatelet rich plasma 610 $aTGF? signaling 610 $atraditional scaffold 610 $apluripotency and commitment 610 $atissue engineered construct 610 $aHLA-G 610 $aCHAPS 610 $aplatelets 610 $aproteomic analysis 610 $avibrating nature of universe. 610 $aVS55 610 $acell culture 610 $aFGF signaling 610 $aevolution of scaffold 610 $adynamicity and dimensionality 610 $afibrin gel 610 $ascaffold classification 610 $adecellularization 610 $avitrification 610 $aseven-folder logics 610 $aIIEF-5 questionnaire 610 $aTGF-?1 610 $aerectile dysfunction 610 $ahuman induced pluripotent stem cells 610 $aiPSCs 610 $ascaffolds 610 $aBarret?s esophagus 610 $anerve regeneration 610 $along term storage 610 $alaws of system evolution 610 $ascaffold categorization 610 $aplatelet lysate 610 $a3D scaffold 610 $aesophagus 610 $alanguage of relativity 610 $acord blood units 615 7$aBiology, life sciences 700 $aMallis$b Panagiotis$01326446 801 0$bScCtBLL 801 1$bScCtBLL 906 $aBOOK 912 $a9910367754503321 996 $aStem Cell and Biologic Scaffold Engineering$93040672 997 $aUNINA